LaVoieHealthScience names James (Jim) Heins as Senior Vice President and Managing Director of its New York Practice

by | Nov 16, 2020

LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, announced the appointment of James (Jim) Heins as Senior Vice President and Managing Director of its New York practice, expanding the agency’s senior leadership team to seven members.

Jim Heins

Jim Heins

In his new role, Heins will provide senior level communications counsel to LHS’s growing roster of biopharmaceutical, medical technology, health IT, and health care services clients. He will also expand the firm’s New York-based integrated investor and public relations team as LHS continues to broaden its footprint within the health care and science sectors.

Heins joins LHS with 30 years of expertise spanning agency and corporate experience, with senior agency roles at H&K Strategies, ICR/Westwicke, and Cooney Waters/Health Unlimited. His experience includes reputation management, branding, public affairs, product communications, media relations, thought leader and patient advocacy engagement, and high-stakes crisis management. He has advised C-suite teams at private and public companies across North America, Asia, and Europe. He has also launched products and conducted executive and franchise positioning campaigns for multinational companies, including Janssen/Johnson & Johnson, Takeda Pharmaceuticals, Abbot Laboratories, Purdue Pharma, and Boehringer Ingelheim. Heins combines his passion for public health and specialized communications skills to implement effective disease awareness and patient engagement programs through traditional, digital, and social media channels.

Donna L. LaVoie, founder and CEO of LaVoieHealthScience commented on Heins’ joining the firm, “This is an important time in our agency’s evolution, and we are excited to add Jim to our team of seasoned specialized thinkers. His combination of health care agency experience and client-side communications expertise makes him a natural fit for our firm as we support public and privately held health and science companies that are improving health care and patient outcomes through innovation.”

Earlier in his career, Heins worked as an in-house communications executive within the pharmaceutical industry. As Senior Director of Corporate Affairs & Communications at Purdue Pharma, he led external and internal communications and managed high-profile issues related to product liability litigation, legislative/regulatory actions, and corporate restructurings. Prior to joining Purdue, he was responsible for corporate reputation, product marketing communications, and employee engagement at Boehringer Ingelheim (USA), where he played a key in creating a unified global brand for the company.

Jim received his Bachelor of Arts in English/Journalism from the University of Richmond in Richmond, VA.

Daily PR Updates

Essential PR industry news, opinion, and analysis delivered to your inbox daily.

Bulldog Reporter
Bulldog Reporter is a leader in media intelligence supplying news, analysis and high-level training content to public relations and corporate communications professionals with the mission of helping these practitioners achieve superior competitive performance.

RECENT ARTICLES

Retailers are racing to achieve faster data-driven insights

Retailers are racing to achieve faster data-driven insights

Since the pandemic started, 87 percent of retail organizations in the U.S. have been under pressure to make data-driven decisions faster. New research from analytics database Exasol quantifies how retailers are heightening data-driven decision-making cycles to meet...